Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

“Magnitude Of Deterioration”: Wall Street Stunned By LVMH’s Earnings

% of readers think this story is Fact. Add your two cents.


“Magnitude Of Deterioration”: Wall Street Stunned By LVMH’s Earnings

LVMH Moët Hennessy shares dropped in Paris trading Tuesday after the luxury conglomerate reported Q1 earnings that fell short of Bloomberg Consensus estimates. The miss was driven by softening demand for high-end goods in top markets such as Asia and the U.S., as a deepening trade war pressured consumer sentiment. 

LVMH’s first-quarter results served as a luxury gut-check for the industry, with a broad-based miss across segments and regions led by sliding demand in key markets, including China and the U.S. Fashion and Leather Goods — the group’s growth engine — also stumbled, signaling concerns about a wider slowdown in the high-end consumer space. 

Here’s a summary of the first quarter results: 

Red Flags:

Organic Revenue -3% vs. +1.1% est. (Bloomberg Consensus): A troubling miss, signaling a sharp deterioration in underlying business momentum.

China and U.S. Weakness:

  • Asia ex-Japan -11% vs. -4.69% est.

  • U.S. -3% vs. +1.19% est.

  • These are core markets for LVMH, and their underperformance is very concerning, especially given the exploding trade war in recent weeks. 

Fashion & Leather Goods -5% vs. -0.55% est.: This is LVMH’s crown jewel segment, and this large miss spooked investors.

Perfumes & Cosmetics -1% vs. +2.1% est. and Selective Retailing -1% vs. +3.69% est.: Both suggest consumers are dialing back on both essentials and discretionary luxury.

Geographic Weakness:

  • U.S. organic revenue -3%, estimate +1.19%

  • Asia excluding Japan organic revenue -11%, estimate -4.69%

  • Japan organic revenue -1%, estimate +4.32%

  • Europe organic revenue +2%, estimate +3.37%

Revenue Shortfall:

Total Revenue €20.31B vs. €21.14B est. (-1.9% y/y): This reflects how demand erosion is hitting the top line hard.

  • Fashion & Leather -3.6% y/y vs. €10.56B est.

  • Perfume & Cosmetics -0.2% y/y vs. €2.26B est.

Softening: 

  • Wines & Spirits -9% vs. -4.49% est.

  • Watches & Jewelry flat vs. +2.4% est.: Avoided contraction, but still a miss in the context of expected growth.

Commenting on LVMH’s first quarter report, Goldman analyst Natasha de la Grense told clients:

The key thing that stood out to me on LVMH’s Q1 miss was that the company attributed most of the slowdown to comp effects i.e. Chinese spending in Japan and Sephora in the U.S. This means we haven’t yet seen the impact of recent events upon the business. Consensus assumes an acceleration to +1% (from -5%) for F&L in Q2 which won’t happen given 1) the April shock to confidence, wealth effects and transatlantic tourist flows; 2) the fact that the comp in Japan gets 25 ppts tougher; 3) the Yen has strengthened vs RMB. Management said U.S. cluster spending was positive in Q1 for F&L but conceded “April might be different”. We suspect that was supported by U.S. tourist spending in Europe which has softened given recent USD weakening/anti-US sentiment. GSe F&L -8% in Q2.

In a separate note, Goldman analysts Louise Singlehurst and others told clients that one key surprise in the earnings report was the ”magnitude of the deterioration in the largest division, Fashion and Leather.” She lowered her 12-month price target by 13% to 630 euros (from 725 euros). 

Here’s more from Singlehurst:

Valuation – PT lowered by 13% to PT €630 (from €725): We continue to use a DCF valuation methodology for LVMH (8.5% WACC, 3.0% LT growth; unchanged). Our price target decreases 13% which reflects (i) a -10% decrease in our long-term earnings and FCF forecasts and (ii) a -3% impact from FX. We acknowledge that the lack of visibility around the demand environment for high-end discretionary goods, coupled with the level of operational gearing (manufacturing, distribution) will likely weigh on investor appetite for the luxury peers in the current market backdrop. However, we remain Buy rated on LVMH as we continue to see the group ranking well versus the broader peer group in its ability to demonstrate market-share leadership, pricing power and scale benefits to support free cash flow performance in a tough macro environment.

More analyst commentary (courtesy of Bloomberg);

UBS (neutral, PT cut to €569 from €650)

  • Sales were much weaker than feared, driven by a strong Chinese deceleration, says analyst Zuzanna Pusz

  • Limited visibility and the high fixed cost nature of the business mean that the end of earnings downgrades is not yet in sight

Stifel (hold, PT €650)

  • Given magnitude of the first-quarter miss and negative implications for margins, analyst Rogerio Fujimori sees 2025 consensus earnings cut by a mid-single-digit percentage

  • Earnings visibility remains limited

Kepler Cheuvreux (buy, PT cut to €675 from €750)

  • LVMH’s shortfall was broad-based, with notable weakness in fashion & leather goods and wines & spirits, analysts say

  • The slowdown is mainly due to softer Chinese spending abroad, especially in Japan, and weaker U.S. demand in aspirational categories

Deutsche Bank (hold, PT cut to €565 from €580)

  • It is now apparent that the fourth quarter was the anomaly for LVMH, says analyst Adam Cochrane, with slowdown in perfumes & cosmetics and Sephora greater than expected and suggesting some weakness with the more aspirational consumer

  • Big investor fear that U.S. is slowing for luxury does not appear to be the case in the first quarter; slowdown in fashion & leather mainly due to weakness in Chinese cluster

Bryan Garnier (buy, PT cut to €730 from €810)

  • LVMH’s first quarter was worse than expected, writes analyst Loic Morvan, with sales momentum softer than anticipated

  • The first quarter faced a still-demanding comparison basis; following the release, analyst sees no 2025 sales growth

Bernstein (outperform, PT €625)

  • Analyst Luca Solca notes that the investor conference all focused on demand in the U.S. given tariffs, with the company’s answers leaving “many disappointed” given it saw no impact on demand in the U.S. in the last weeks of March

Telsey Advisory Group (outperform, PT cut to €715 from €820)

  • LVMH’s first-quarter organic sales decline fell short of the consensus expectation, says analyst Dana Telsey, though Europe was the bright spot

  • Despite near-term disruptions, LVMH has some of the strongest luxury brands in the world and manages them for their long-term success

RBC (outperform, PT to €680 vs €750)

  • Analyst Piral Dadhania writes that investor concerns about underlying demand recovery are likely to be “amplified” based on this report

  • Cuts FY25 Ebit expectations by 8%, including a “more pronounced” reduction in 1H25 * Dadhania expects these softer-than-expected results from “bellwether” LVMH will have negative read-across to the wider luxury sector

Morgan Stanley (equal-weight vs overweight, PT to €590 vs €740)

  • Softer start to year than expected for key fashion and leather goods division and now model similar full-year contraction to top line as in 2024, analyst Edouard Aubin writes

  • 2Q likely to see another contraction in sales, with China continuing to be a major drag and the industry facing a soft macro environment

  • Cuts estimates, rating and PT

JPMorgan (neutral, PT €610 vs €650)

  • Analyst Chiara Battisttini says even the market leader is finding things tough, with a noticeable sequential slowdown vs the previous quarter

  • Volumes slightly slowed, and it’s possible that product mix might have also weighed

  • Lowers estimate by 7%-8% and says the sector’s growth opportunities may have been exhausted

Citi (buy)

  • “LVMH’s ~4% revenue miss will likely set a negative tone for the upcoming reporting season,” with sales for both group and fashion and leather division below even the “most conservative buyside expectations,” analyst Thomas Chauvet writes

  • Tough to see a “credible scenario” of sequential top-line improvement for 2Q/3Q (for LVMH and luxury peers) given “highly elevated” economic uncertainty in the U.S. and globally

Bloomberg Intelligence

  • LVMH’s weak start “fuels concern over luxury-market outlook” as uncertainty around tariffs grows, analyst Deborah Aitken writes

  • “A slowdown in Chinese spending in Japan and Sephora in the US were the main culprits, both vs. big year-ago 1Q gains,” she adds

In markets, LVMH shares in Paris are down 7.5%, trading at lows not seen since late 2020 as the luxury bubble unwinds. 

Rival Hermès International’s market capitalization has surpassed LVMH’s, making it the world’s most valuable luxury brand — a milestone two decades after LVMH’s Bernard Arnault once attempted a takeover of Hermès.

Meanwhile, on TikTok … 

.   .   . 

Tyler Durden Tue, 04/15/2025 – 08:05


Source: https://freedombunker.com/2025/04/15/magnitude-of-deterioration-wall-street-stunned-by-lvmhs-earnings/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.